FDA Has Taken Several Steps in Recent Years to Support Increased Availability of Opioid Overdose Reversal Drug The U.S. Food and Drug Administration will host a virtual public workshop on Mar. 29, to discuss critical questions around access to naloxone, a drug used to reverse opioid overdoses. The workshop is a collaboration with the Reagan-Udall Foundation for…

Continue Reading